Myomo (MYO) Equity Ratio (2016 - 2025)
Myomo posted quarterly Equity Ratio of 0.3 for Q4 2025, down 49.55% year-on-year from 0.59 in Q4 2024, and down 31.23% on a QoQ basis from 0.43 in Q3 2025.
Myomo (MYO) has 10 years of Equity Ratio data on file, last reported at 0.3 in Q4 2025.
- For the quarter ending Q4 2025, Equity Ratio fell 49.55% year-over-year to 0.3; the trailing twelve-month figure through Dec 2025 stood at 0.3 (down 49.55% YoY), and the FY2025 full-year result was 0.3, down 49.55% from the prior year.
- Equity Ratio for Q4 2025 stood at 0.3, down from 0.43 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.78 in Q2 2021 and bottomed at 0.3 in Q4 2025.
- The 5-year median for Equity Ratio is 0.64 (2022), against an average of 0.63.
- The widest annual swing landed in 2021, when Equity Ratio increased 3.7%; it then slumped 49.55% in 2025.
- A 5-year view of Equity Ratio shows it stood at 0.77 in 2021, then slipped by 18.39% to 0.63 in 2022, then declined by 1.49% to 0.62 in 2023, then decreased by 5.1% to 0.59 in 2024, then plunged by 49.55% to 0.3 in 2025.
- The last three Equity Ratio figures came in at 0.3 (Q4 2025), 0.43 (Q3 2025), and 0.46 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.47 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.50 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.54 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.59 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.78 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.45 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.29 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.67 |
| 10 | Myomo | 44.63 Mn | 26.23 Mn | - | 0.30 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.30 |
| Sep 30, 2025 | 0.43 |
| Jun 30, 2025 | 0.46 |
| Mar 31, 2025 | 0.53 |
| Dec 31, 2024 | 0.59 |
| Sep 30, 2024 | 0.57 |
| Jun 30, 2024 | 0.60 |
| Mar 31, 2024 | 0.66 |
| Dec 31, 2023 | 0.62 |
| Sep 30, 2023 | 0.65 |
| Jun 30, 2023 | 0.66 |
| Mar 31, 2023 | 0.70 |
| Dec 31, 2022 | 0.63 |
| Sep 30, 2022 | 0.64 |
| Jun 30, 2022 | 0.71 |
| Mar 31, 2022 | 0.72 |
| Dec 31, 2021 | 0.77 |
| Sep 30, 2021 | 0.75 |
| Jun 30, 2021 | 0.78 |
| Mar 31, 2021 | 0.77 |
| Dec 31, 2020 | 0.79 |
| Sep 30, 2020 | 0.85 |
| Jun 30, 2020 | 0.78 |
| Mar 31, 2020 | 0.74 |
| Dec 31, 2019 | 0.97 |
| Sep 30, 2019 | 0.73 |
| Jun 30, 2019 | 0.83 |
| Mar 31, 2019 | 0.85 |
| Dec 31, 2018 | 0.78 |
| Sep 30, 2018 | 0.83 |
| Jun 30, 2018 | 0.88 |
| Mar 31, 2018 | 0.92 |
| Dec 31, 2017 | 0.89 |
| Sep 30, 2017 | 0.43 |
| Jun 30, 2017 | 0.50 |
| Dec 31, 2016 | -10.57 |